Résumé
Dans le traitement des effets de la ménopause, les oestrogènes ont fait leur preuve en palliant à toutes les manifestations cliniques apparentes et inapparentes de l’extinction de la fonction ovarienne [2]. Toutefois, même en association avec un progestatif, et dans une certaine mesure à cause de cette association avec un progestatif [7], les traitements substitutifs à base d’oestrogènes donnent lieu à des effets secondaires qui rendent souhaitable de disposer de solutions alternatives et incitent à développer de nouvelles formes de traitement, par exemple par le choix d’autres formes galéniques ou la mise au point de nouvelles molécules. Quelles sont donc les perspectives dans ce domaine?
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Bibliographie
Birkhäuser MH (1988) Central and peripheral effects of vaginal estrogen therapy. In: Genazzani AR, Montemagno V, Nappi C, Petraglia F (eds) The brain and female reproduction function. Parthenon, Casterton Hall, pp 601–608
Christiansen C (1988) Estrogentherapy of osteoporosis. Dans: The Proceedings of a Special Symposium held at the First Congress of the International Society of Gynecological Endocrinology. In: Christiansen C (ed) New horizons in osteoporosis. Parthenon, Casterton Hall, pp 13–19
Clayden JR, Bell JW, Pollard P (1974) Menopausal flushing: double-blind trial of a non-hormonal medication. Br Med J 1: 409–412
David A, Don R, Tajchner G, Weissglas L (1988) Vaeralipride: alternative antidopaminergic treatment for menopausal symptoms. Am J Obstet Gynecol 158: 1107–1115
De Aloysio D, Fabiani AG, Maufoni M, Bottiglioni F (1987) Use of Org OD 14 for the treatment of climateric complaints. Maturitas [Suppl] 1: 49–65
Delanian L (1980) Etude clinique de l’activité d’une nouvelle molécule de veralipride sur les troubles psychoneuro-végétatifs de la ménopause. Sem Hop Paris 56: 1468–1470
Don Gambrell R jr (1987) Estrogen replacement therapy — guidelines for safe use. Drug Therapy 68: 80
Edington RF, Chagman JP, Steinberg WM (1980) Clonidine (Dixarit) for menopausal flushing. Can Med Assoc J 123: 23–26
Ginsburg J, Reilly O, Swinhoe J (1985) Effect of oral Clonidine on human cardiovascular responsiveness: a possible explanation of the therapeutic action of the drug in menopausal flushing and migraine. Br J Obstet Gynaecol 92: 1169–1175
Holmgren PA, Lindskog M, von Schoultz B (1989) Vaginal rings for continuous lowdose release of oestradiol in the treatment of urogenital atrophy. Maturitas 11: 55–63
Keller PJ (1988) Transdermal systems for estrogentherapy in menopause. In: Genazzani AR, Montemagno V, Nappi C, Petraglia F (eds) The brain and female reproduction. Parthenon, Casterton Hall, pp 601–609
Keller PJ (1988) Combined transdermal hormone therapy. In: Genazzani AR, Petraglia F, Volpe A, Facchinetti F (eds) Advances in gynaecological andocrinology. Parthenon, Carnforth, pp 651–657
Kicovic PM, Cortes-Prieto J, Luisi M, Milojevic S, Franchi F (1982) Placebo-controlled crossover study of effects of Org OD 14 in menopausal women. Reproduction 6: 81–91
Kicovic PM (1988) New steroid for the climateric syndrome. In: Gemazzani AR, Montemagno V, Nappi C, Petraglia F (eds) The brain and female reproductive function. Parthenon, Casterton Hall, pp 610–616
Laufer LR (1982) Effect of Clonidine on hot flashes in postmenopausal women. Obstet Gynecol 60: 583–586
Linquette M, Riviere J, Vague J (1980) Traitement non hormonal des troubles de la ménopause — étude multicentrique en double insu. Sem Hop Paris 56: 1445–1448
Lufkin EG, Carpenter PC, Ory SJ, Malkesian GD, Edmonson J-H (1988) Estrogen replacement therapy: current recommendations. Mayo Clin Proc 63: 453–460
Metzger DA, Hammond CB (1988) Are estrogens indicated for the treatment of postmenopausal women. Drug Intell Clin Pharm 22: 493–496
Mishell DR, Moore DE, Roy S, Brenner PF, Page MA (1978) Clinical performance and endocrine profile with contraceptive vaginal ring containing a combination of estradiol and d-norgestrel. Am J Obstet Gynecol 130: 55–62
Nagomani M, Kelver ME, Smith ER (1987) Treatment of menopausal hot flashes with transdermal administration of Clonidine. Am J Obstet Gynecol 156: 561–565
Reginster JY, Denis D, Albert A, Deroisy R, Leeart MP, Fontaine MA, Franchimont P (1988) Intranasal calcitonin: a new horizon in prevention of early postmenopausal boneloss. In: Christiansen C (ed) New horizons in osteoporosis. Parthenon, Carnforth, pp 27–35
Riis BJ, Christiansen C, Overgaard K (1988) The effect of nasal calcitonine on postmenopausal oestoporosis. In: Christiansen C (ed) New horizons in osteoporosis. Parthenon, Carnforth, pp 37–41
Sandrin R, Evrard G, Adnet JJ, Wahl P, Quereux C (1980) Etude cytologique hormonale des frottis vaginaux avant et après traitement par veralipride. Sem Hop Paris 56: 1460–1464
Salmi T, Punnonen R (1979) Clonidine in the treatment of menopausal symptoms. Int J Gynaecol Obstet 16: 422–426
Sitruk-Ware R (1988) Editorial. Maturitas 10: 79–81
Stevenson JC, Cush MP, Ganger KF (1988) Calcitonin and estrogen in the management of osteoporosis. In: Christiansen C (ed) New horizons in oestoporosis. Parthenon, Carnforth, pp 21–26
Tax L, Goorissen EM, Kicovic PM (1987) Clinical profile of Org OD 14. Maturitas [Suppl] 1: 3–13
Treroux R, Dieulangard P, Blum A (1983) Efficacy and safety of Org OD 14 in the treatment of climateric complaints. Maturitas 5: 89–96
Tulandi T, Lal S, Kinch RA (1983) Effect of intravenous Clonidine on menopausal flushing and luteinizing hormone secretion. Br J Obstet Gynaecol 90: 854–857
Verbeke K, Dhout M, van de Kerckhove D (1988) Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women. Maturitas 10: 225–230
Wesel S, Bosuma WB (1983) L’alternative au traitement hormonal des bouffées vasomotrices de la ménopause: le veralipride. Sem Hop Paris 59: 596–599
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Welti, H.J. (1989). Perspectives et alternatives. In: Verhandlungen der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe. Archives of Gynecology and Obstetrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-37810-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-37810-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-37102-2
Online ISBN: 978-3-662-37810-6
eBook Packages: Springer Book Archive